AP NEWS

Arginine Depletors Pipeline Insights, 2018 Report - ResearchAndMarkets.com

August 24, 2018

DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Arginine Depletors -Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

‘Arginine Depletors - Pipeline Insight, 2018’ report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Arginine Depletors development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Arginine Depletors - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Arginine Depletors - Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Arginine Depletors Pipeline Products in Clinical Stages

6. Arginine Depletors Pipeline Products in Non-clinical Stages

7. Therapeutic Assessment: Active Products

8. Inactive Pipeline Products

Companies Mentioned

Bio-Cancer Treatment International Limited aegleabio Polaris Group ERYTECH

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/42kjfb/arginine?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005405/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/24/2018 02:49 PM/DISC: 08/24/2018 02:49 PM

http://www.businesswire.com/news/home/20180824005405/en

AP RADIO
Update hourly